GeneAssist Therapeutics has snapped “several tens of millions” in US dollars in its Series A round; Singular Medical has snapped “several hundreds of millions” yuan in a Series B+ round; and Witmem Technology has notched 200 million yuan in a Series B2 round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
